Cancer and Pharmacology

Treatment often fails when cancer becomes resistant to anti-cancer drugs. Thus, drug resistance is a big challenge facing the survival of cancer patients. Research in discovering and designing drugs with new chemistry structure or mechanism of action is critical to overcome the drug resistance problem and give patient better chance to survive longer. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to specifically bind to specific cells or proteins. Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future.The clinical toxicology importance of any drug interaction depends on factors that are drug-patient and administration related. Generally, a doubling or more in plasma drug concentration has the potential for enhanced adverse or beneficial drug response Drug interactions in oncology are of particular importance owing to the narrow therapeutic index and the inherent toxicity of anticancer agents. Interactions with other medications can cause small changes in the pharmacokinetics or pharmacodynamics of a chemotherapy agent that could significantly alter its efficacy or toxicity.

Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to specifically bind to specific cells or proteins. Functional genomics is a field of molecular biology that attempts to make use of the vast wealth of data produced by genomic and transcriptomic projects (such as genome sequencing projects and RNA-seq) to describe gene (and protein) functions and interactions. Novel drug delivery is the method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future. Pharmacodynamics is the study of the biochemical and physiological effects of drugs on the body or on microorganisms or parasites within or on the body and the mechanisms of drug action and the relationship between drug concentration and effect.[ Consequently, a number of regulatory issues were discussed at the workshop, including regulatory oversight of the diagnostic tests used in clinical trials and trials focused on small subsets of cancer patients, as well as international differences in regulations and how to harmonize them. 

  • Therapeutic antibodies
  • Functional genomics
  • Novel drug delivery system
  • Cancer drug designing
  • Nanotechnology and nanomedicine
  • Pharmacodynamics and pharmacokinetics
  • Regulatory issues in cancer research

Related Conference of Cancer and Pharmacology

November 11-12, 2019

38th Annual Conference on Advances in Cancer Research and Therapy

| Rafael Hoteles forum Alcala Bulgaria, 2 | 28802 Alcalá de Henares, Madrid, Spain
November 11-12 2019

3rd Cancer Diagnostics & Treatment Conference

Frankfurt, Germany
November 18-19, 2019

5th World Congress on Cancer and Diagnostics

Osaka, Japan
December 4-5, 2019

Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
February 10-11, 2020

24th Global Annual Oncologists Meeting

Auckland, New Zealand
November 11-12, 2020

4th Global Summit on Cancer

Tokyo, Japan
March 30-31 | 2020

20th Global Cancer Summit

| Kyoto, Japan
April 13-14, 2020

World Congress on Women Oncology & Care

Tokyo , Japan
April 29-30, 2020

11th Euro Breast Cancer Summit

Prague, Czech Republic
June 11-12 | 2020

10th World Congress on Breast Cancer & Therapies

| Singapore
June 15-16, 2020

5th World Congress on Cancer and Diagnostics

Berlin, Germany
June 22-23, 2020

18th Asia Pacific
Oncologists Annual Meeting

Brisbane, Australia
June 24-25, 2020

7th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
July 09-10, 2020

5th International Conference on Preventive Oncology

Berlin, Germany
September 14-15, 2020

16th World Congress on Blood Cancer

Vienna, Austria
November 16-17, 2020

International Conference on Frontiers in Lung Cancer

Brisbane, Australia
November 25-26, 2020

39th World Cancer Conference

Rome, Italy

Cancer and Pharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in